You just read:

Collaboration with Dr Stephen Waxman of Yale University to Evaluate Pharmacology of Nav1.7 Mutations in Chronic Pain Disorders

News provided by

Convergence Pharmaceuticals

Oct 06, 2014, 02:00 ET